ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,846.40
      0.00%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.315
      -1.22%
      Bitcoin
      64,644.34
      -0.32%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Novo Nordisk (NVO)

      7. Novo Nordisk (NVO) Financials

      Novo Nordisk

      Novo Nordisk (NVO)

      140.87
      -0.52
      (-0.37%)
      At close: July 16 4:00PM
      Delayed by 15 minutes
      140.90
      0.03
      ( 0.02% )
      After Hours: 6:41PM
      Delayed by 15 minutes

      Novo Nordisk Financial Summary

      The current NVO market cap is 628.73B. The company's latest EPS is DKK 18.7536 and P/E is 7.60.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 53.37B54.3B58.73B65.86B65.35B
      Operating Income 25.01B23.89B26.91B26.85B31.85B
      Net Income 19.81B19.43B22.48B21.96B25.41B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 122.02B126.95B140.8B176.95B232.26B
      Operating Income 52.35B54.28B58.62B74.62B102.66B
      Net Income 38.95B42.14B47.76B55.53B83.68B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 250.03B280.75B300.1B314.49B298.92B
      Total Liabilities 170.15B190.28B207.11B207.93B200.01B
      Total Equity 79.87B90.47B92.99B106.56B98.91B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 125.61B144.92B194.51B241.26B314.49B
      Total Liabilities 68.02B81.6B123.76B157.77B207.93B
      Total Equity 57.59B63.33B70.75B83.49B106.56B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 29.81B58.39B99.36B108.91B14.31B
      Investing -6.65B-15.93B-29.18B-43.89B3.96B
      Financing -20.62B-33.21B-53.04B-63.16B-26.38B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 46.78B51.95B55B78.89B108.91B
      Investing -11.51B-22.44B-31.61B-24.92B-43.89B
      Financing -35.48B-32.24B-25.49B-51.8B-63.16B

      Stats and Ratios

      Market Cap 628.73B
      Price to Earnings Ratio 7.60
      Price to Sales Ratio 2.74
      Price to Cash Ratio 44.21
      Price to Book Ratio 5.97
      Dividend Yield 1.28%

      Share Statistics

      Shares Outstanding 4.46B
      Average Volume (1 week) 3.35M
      Average Volume (1 Month) 3.88M
      52 Week Change 74.44%
      52 Week High 148.15
      52 Week Low 77.955
      Spread (Intraday) 0.45 (0.32%)

      Company Info

      Company Name Novo Nordisk
      Address novo alle
      bagsvaerd DK-2880
      Website https://www.novonordisk.com
      Industry pharmaceutical preparations (2834)